This is a news story, published by ScienceDaily, that relates primarily to RSV news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from ScienceDaily, you can click here:
more news from ScienceDailyOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
dangerous Respiratory Syncytial Virus. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest RSV infection news, antiviral genes news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Respiratory syncytial virus NS1ScienceDaily
•72% Informative
Irish scientists led by a group from Trinity College Dublin have discovered how the dangerous Respiratory Syncytial Virus ( RSV ) defuses our immune response.
In doing so, they have pinpointed an exciting new target for drug developers.
RSV causes a significant disease burden in the global population, with an estimated 33.1 million cases each year .
VR Score
77
Informative language
82
Neutral language
13
Article tone
formal
Language
English
Language complexity
76
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links